Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label, randomized study of prednisone plus Adacolumn granulocyte/monocyte apheresis versus prednisone alone in corticosteroid-dependent mild to moderate ulcerative colitis
2007-003815-30Phase 3Terminated
- Sponsor
- GETECCU
- Start
- Oct 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of prednisone in autoimmune colitis (2 arms), sponsored by GETECCU. Primary endpoint: Primary efficacy and safety response variable. Started Oct 2007; status: terminated.
02
Drugs
prednisone
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2007-003815-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003815-30.